| __timestamp | Ligand Pharmaceuticals Incorporated | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 27632226 |
| Thursday, January 1, 2015 | 66107000 | 97707000 |
| Friday, January 1, 2016 | 103402000 | 129037000 |
| Sunday, January 1, 2017 | 135736000 | 151332000 |
| Monday, January 1, 2018 | 245116000 | 158719000 |
| Tuesday, January 1, 2019 | 108935000 | 170104000 |
| Wednesday, January 1, 2020 | 156000000 | 192195000 |
| Friday, January 1, 2021 | 214957000 | 220706000 |
| Saturday, January 1, 2022 | 143418000 | 204426000 |
| Sunday, January 1, 2023 | 96265000 | 133788000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, Ligand Pharmaceuticals Incorporated and Travere Therapeutics, Inc. have shown intriguing patterns in their gross profits. From 2014 to 2023, Ligand Pharmaceuticals experienced a significant rise, peaking in 2018 with a 342% increase from its 2014 figures. However, recent years have seen a decline, with 2023 figures dropping by 61% from their peak.
Conversely, Travere Therapeutics has demonstrated a more consistent upward trajectory, with gross profits increasing by 384% from 2014 to 2021. Despite a slight dip in 2023, Travere's growth remains robust, showcasing resilience in a competitive market. These trends highlight the dynamic nature of the pharmaceutical industry, where strategic decisions and market conditions can significantly impact financial outcomes.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Sanofi vs Travere Therapeutics, Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown